1. All aglow about presynaptic receptor regulation of neurotransmitter transporters. Blakely RD, DeFelice LJ (2007) Mol Pharmacol 71(5): 1206-8
    › Primary publication · 17329498 (PubMed)
  2. Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants. Henry LK, Field JR, Adkins EM, Parnas ML, Vaughan RA, Zou MF, Newman AH, Blakely RD (2006) J Biol Chem 281(4): 2012-23
    › Primary publication · 16272152 (PubMed)
  3. The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Zhu CB, Blakely RD, Hewlett WA (2006) Neuropsychopharmacology 31(10): 2121-31
    › Primary publication · 16452991 (PubMed)
  4. The N-terminus of the norepinephrine transporter regulates the magnitude and selectivity of the transporter-associated leak current. Binda F, Lute BJ, Dipace C, Blakely RD, Galli A (2006) Neuropharmacology 50(3): 354-61
    › Primary publication · 16289633 (PubMed)
  5. The high-affinity choline transporter: a critical protein for sustaining cholinergic signaling as revealed in studies of genetically altered mice. Bazalakova MH, Blakely RD (2006) Handb Exp Pharmacol (175): 525-44
    › Primary publication · 16722248 (PubMed)
  6. The Caenorhabditis elegans choline transporter CHO-1 sustains acetylcholine synthesis and motor function in an activity-dependent manner. Matthies DS, Fleming PA, Wilkes DM, Blakely RD (2006) J Neurosci 26(23): 6200-12
    › Primary publication · 16763028 (PubMed)
  7. Serotonin-, protein kinase C-, and Hic-5-associated redistribution of the platelet serotonin transporter. Carneiro AM, Blakely RD (2006) J Biol Chem 281(34): 24769-80
    › Primary publication · 16803896 (PubMed) · PMC3875312 (PubMed Central)
  8. Norepinephrine transporter-deficient mice respond to anxiety producing and fearful environments with bradycardia and hypotension. Keller NR, Diedrich A, Appalsamy M, Miller LC, Caron MG, McDonald MP, Shelton RC, Blakely RD, Robertson D (2006) Neuroscience 139(3): 931-46
    › Primary publication · 16515844 (PubMed)
  9. Na+, Cl-, and pH dependence of the human choline transporter (hCHT) in Xenopus oocytes: the proton inactivation hypothesis of hCHT in synaptic vesicles. Iwamoto H, Blakely RD, De Felice LJ (2006) J Neurosci 26(39): 9851-9
    › Primary publication · 17005849 (PubMed)
  10. High affinity inhibitors of the dopamine transporter (DAT): novel biotinylated ligands for conjugation to quantum dots. Tomlinson ID, Mason JN, Blakely RD, Rosenthal SJ (2006) Bioorg Med Chem Lett 16(17): 4664-7
    › Primary publication · 16784853 (PubMed)